(0.12%) 5 333.50 points
(0.03%) 40 148 points
(0.16%) 18 665 points
(-0.37%) $79.76
(0.53%) $2.64
(1.30%) $2 448.80
(3.11%) $32.23
(0.31%) $1 093.40
(0.05%) $0.920
(0.01%) $10.68
(0.03%) $0.787
(-0.31%) $90.68
Live Chart Being Loaded With Signals
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules...
Stats | |
---|---|
Today's Volume | 50 929.00 |
Average Volume | 139 366 |
Market Cap | 180.63M |
EPS | $0 ( 2024-05-09 ) |
Next earnings date | ( $-0.100 ) 2024-08-05 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.92 |
ATR14 | $0.00500 (0.32%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-08 | Vazquez Chris | Buy | 601 | Common Stock |
2024-05-09 | Vazquez Chris | Sell | 244 | Common Stock |
2024-05-08 | Vazquez Chris | Sell | 601 | Restricted Stock Units |
2024-05-08 | Pestano Gary Anthony | Buy | 1 378 | Common Stock |
2024-05-09 | Pestano Gary Anthony | Sell | 434 | Common Stock |
INSIDER POWER |
---|
88.48 |
Last 100 transactions |
Buy: 13 138 197 | Sell: 610 168 |
Volume Correlation
Biodesix, Inc. Correlation
10 Most Positive Correlations | |
---|---|
TBNK | 0.943 |
LBRDA | 0.934 |
PTSI | 0.934 |
LBRDK | 0.933 |
LTRX | 0.931 |
EBMT | 0.931 |
VLCN | 0.929 |
CNOB | 0.926 |
INVA | 0.925 |
CBAN | 0.923 |
10 Most Negative Correlations | |
---|---|
EZPW | -0.923 |
FAAR | -0.918 |
MOR | -0.908 |
ZENV | -0.906 |
EVBG | -0.903 |
ADSE | -0.892 |
META | -0.887 |
OWL | -0.883 |
DUSA | -0.883 |
CRTO | -0.883 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Biodesix, Inc. Correlation - Currency/Commodity
Biodesix, Inc. Financials
Annual | 2023 |
Revenue: | $49.09M |
Gross Profit: | $33.21M (67.66 %) |
EPS: | $-0.640 |
FY | 2023 |
Revenue: | $49.09M |
Gross Profit: | $33.21M (67.66 %) |
EPS: | $-0.640 |
FY | 2022 |
Revenue: | $38.21M |
Gross Profit: | $24.06M (62.96 %) |
EPS: | $-1.910 |
FY | 2021 |
Revenue: | $54.51M |
Gross Profit: | $54.51M (100.00 %) |
EPS: | $-1.580 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Biodesix, Inc.
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also offers GeneStrat ddPCR and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions; and GeneStrat NGS (NGS) test, a 72-hour blood-based NGS test. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. Biodesix, Inc. was incorporated in 2005 and is headquartered in Boulder, Colorado.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators